Orforglipron
A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight
Eli Lilly · Phase 1 · Completed · Enrollment 533
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.